Literature DB >> 1346955

Specificity and mode of action of the muscle-type protein-arginine deiminase.

K Nomura1.   

Abstract

The primary and secondary specificities and mode of action of the muscle-type protein-arginine deiminase (PAD) were investigated using various derivatives of Arg and its homologues, as well as Arg-containing peptides by quantitative analyses of the reaction products on reverse-phase HPLC. The enzyme converted benzoyl-D-Arg-p-nitroanilide into its citrulline derivative at 18% of the rate of the L-isomer, while the D-Arg residues in peptides were not deiminated to a significant extent. This suggests that PAD does not have strict stereospecificity and it is dependent on the structure of the residues or groups on both sides of the target Arg residue. In contrast, the benzoyl-/-ethyl ester derivatives of homoarginine, alpha-amino-beta-guanidino-propionic acid, canavanine, and NG-methyl-Arg, exhibited poor PAD susceptibility, suggesting that the length and nature of the arm as exactly three CH2 groups, and the integrity of the guanidyl group are quite strict specificity determinants. The enzyme action on Arg residues in peptides depends greatly on their position in the sequence, and on the nature of the neighboring residues. For example, deimination of Arg residues situated at positions 1-3 from the NH2-terminus, except for those preceded by a carbobenzoxy- or benzoyl-group, were in most cases very slow, whereas those at the COOH-terminus were deiminated relatively faster. A single Arg residue sandwiched between two Pro residues was not deiminated at all, while a pair of Arg residues between two Pro were deiminated moderately. Consequently, PAD exhibited a variety of modes of action on more than one Arg residues in the peptides tested. The results suggest the applicability of PAD, albeit quite limited, for selective modification of certain Arg residues in peptides and proteins by appropriately controlling reaction time and several other parameters. The PAD's mode of action was compared with those of three Arg-bond cleaving proteases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346955     DOI: 10.1016/0003-9861(92)90407-n

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

Review 1.  Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation.

Authors:  Erin E Witalison; Paul R Thompson; Lorne J Hofseth
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 2.  Chemical biology of protein arginine modifications in epigenetic regulation.

Authors:  Jakob Fuhrmann; Kathleen W Clancy; Paul R Thompson
Journal:  Chem Rev       Date:  2015-05-13       Impact factor: 60.622

3.  Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.

Authors:  Erika Darrah; Antony Rosen; Jon T Giles; Felipe Andrade
Journal:  Ann Rheum Dis       Date:  2011-08-21       Impact factor: 19.103

4.  Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?

Authors:  M-K Koivula; S Aman; A Karjalainen; M Hakala; J Risteli
Journal:  Ann Rheum Dis       Date:  2005-10       Impact factor: 19.103

Review 5.  A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease.

Authors:  George Harauz; Abdiwahab A Musse
Journal:  Neurochem Res       Date:  2006-08-09       Impact factor: 3.996

6.  Expression of peptidylarginine deiminase from Porphyromonas gingivalis in Escherichia coli: enzyme purification and characterization.

Authors:  Sofía B Rodríguez; Barbara L Stitt; David E Ash
Journal:  Arch Biochem Biophys       Date:  2009-06-21       Impact factor: 4.013

7.  Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4+ T Cells in Multiple Sclerosis.

Authors:  Wolfgang Faigle; Carolina Cruciani; Witold Wolski; Bernd Roschitzki; Marco Puthenparampil; Paula Tomas-Ojer; Carla Sellés-Moreno; Thomas Zeis; Ivan Jelcic; Nicole Schaeren-Wiemers; Mireia Sospedra; Roland Martin
Journal:  Front Immunol       Date:  2019-04-10       Impact factor: 7.561

8.  Deiminated proteins in extracellular vesicles and serum of llama (Lama glama)-Novel insights into camelid immunity.

Authors:  Michael F Criscitiello; Igor Kraev; Sigrun Lange
Journal:  Mol Immunol       Date:  2019-11-13       Impact factor: 4.407

9.  The Proteome and Citrullinome of Hippoglossus hippoglossus Extracellular Vesicles-Novel Insights into Roles of the Serum Secretome in Immune, Gene Regulatory and Metabolic Pathways.

Authors:  Bergljót Magnadóttir; Igor Kraev; Alister W Dodds; Sigrun Lange
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

10.  Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.

Authors:  Pinar Uysal-Onganer; Amy MacLatchy; Rayan Mahmoud; Igor Kraev; Paul R Thompson; Jameel M Inal; Sigrun Lange
Journal:  Int J Mol Sci       Date:  2020-02-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.